ALAMEDA, Calif.– BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today reported financial results for the first quarter ended March 31, 2013 and highlighted recent corporate accomplishments. First Quarter and Recent Corporate Accomplishments Entered into an Asset Contribution Agreement with Geron Corporation (“Geron”) and […]
Ipswich, MA – New England Biolabs (NEB), a world leader in the discovery and production of reagents for the life science industry, launched a new reagent kit for site-directed mutagenesis (SDM). The Q5® Site-Directed Mutagenesis Kit (Q5 SDM Kit) is capable of introducing long insertions and deletions, thus allowing a broader range of applications for […]
Billerica, MA and London, UK — EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, and Plasticell of London, UK, today announced the availability of OsteoMAX-XF™, the first fully defined, xeno-free human mesenchymal stem cell differentiation medium for the differentiation of mesenchymal stem cells into osteocytes. Mineralization can be detected in less […]
SAN DIEGO – TriLink BioTechnologies Inc. (TriLink, trilinkbiotech.com), a leader in manufacturing high quality oligonucleotides, nucleoside triphosphates and mRNA, announced that it has signed a licensing agreement with QuantiBact A/S (QuantiBact, quantibact.com) to offer twisted intercalating nucleic acid (TINA) modified oligos. TINA molecules are intercalators placed at the 5′ end of primers to stabilize duplex […]
SAN DIEGO – TriLink BioTechnologies Inc. (TriLink, trilinkbiotech.com), a leader in manufacturing high quality oligonucleotides, nucleoside triphosphates and mRNA, announced that it has signed a licensing agreement with QuantiBact A/S (QuantiBact, quantibact.com) to offer twisted intercalating nucleic acid (TINA) modified oligos. TINA molecules are intercalators placed at the 5′ end of primers to stabilize duplex […]
IRVINE, Calif., — GeneTex, Inc., a leading manufacturer of antibodies and antibody-related reagents, is introducing a new mouse monoclonal antibody to the human Ten-Eleven Translocation 1 (TET1) protein. The discovery in 2009 (Tahiliani et al, 2009) that this enzyme can convert the DNA methylation mark 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) helped to usher in a […]
SAN DIEGO, — GenWay Biotech today announced the appointment of Michael Dale as the Company’s new Vice President of Custom Laboratory Services. In this role, Mr. Dale will be responsible for providing leadership for GenWay Biotech Custom Services operations and business development initiatives. “As a key member of the GenWay Biotech senior management team, Mr. […]
Ipswich, MA – New England Biolabs (NEB) announces the release of the NEBNext® Microbiome DNA Enrichment Kit, which uses a novel method to separate microbial DNA from host DNA, thereby reducing the high cost of sequencing microbiome DNA to a more practical level. Microbiome samples are commonly dominated by host DNA (up to 99%). This […]
Hercules, CA —— Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, announced financial results today for the first quarter ended March 31, 2013. First-quarter reported revenues were $499.7 million, up 2.8% compared to $486.3 million reported for the first quarter of 2012. These […]
CAMBRIDGE, Mass.–Firefly BioWorks announced today the awarding of three Firefly Frontiers Grants to leading researchers engaged in pushing the boundaries of microRNA research. The Frontiers Grant, a $10,000 award to be used on the company’s products, is designed to help scientists scale microRNA research from discovery to validation. Three of the Frontiers Grant winners are: […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
